Jeffrey del Carmen, Chief Commercial Officer at CATALYST PHARMACEUTICALS, INC. (CPRX), sold 80,000 shares at $16.69 ($1.3M) on 2023-03-29, disclosed to the SEC on 2023-03-30.
Open-market sale of $1.3M CPRX by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.69 | 19,017 | $317K | 23.8% |
| 2 | $16.69 | 19,017 | $317K | 23.8% |
| 3 | $16.70 | 20,983 | $350K | 26.2% |
| 4 | $16.70 | 20,983 | $350K | 26.2% |
| Total | $16.70 avg | 80,000 | $1.3M | 100% |
| Filing → |
| CPRX | SELL | 2024-08-13 | $776K | — | Filing → |
| CPRX | SELL | 2024-06-11 | $242K | — | Filing → |
| CPRX | SELL | 2022-11-15 | $2.5M | — | Filing → |